Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J0KT
|
|||
| Former ID |
DCL000216
|
|||
| Drug Name |
RhuDex
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2a | [1] | |
| Company |
MediGene AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. | |||
| REF 2 | A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma. Clin Cancer Res. 2011 Apr 1;17(7):1998-2005. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.